Utilizamos cookies para facilitar el uso de nuestro sitio web, mejorar nuestros productos, adaptarlos a sus necesidades y mostrarle publicidad personalizada y no personalizada relevante
Tirzepatide is a dual agonist that activates both the GLP-1 receptor and the GIP receptor
we check thyroid levels before prescribing levothyroxine, testosterone and estrogen before starting hormone replacement, insulin secretion capacity before choosing between diabetes drug classes
A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis
Furthermore, the L-carnitine group exhibited greater reductions in anthropometric parameters, including lean body mass (LBM) and body fat mass (BFM), relative to the placebo group (Nachvak et al
Drug-drug interactions are uncommon with GLP-1 receptor agonists because they are not metabolized by cytochrome P450 enzymes